2BB score and signals
Kura Oncology, Inc.’s current 2BB score is 56 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 72 | High |
| Momentum | 57 | Stable |
| Financial strength | 10 | Very Weak |
| Quality | 98 | Very Strong |
| Risk | 58 | Moderate |
Company facts
| Headquarters | San Diego, California, United States |
| Founded | 2014 |
| Employees | 260 |
| 52-week range | $7.36 – $13.90 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2027-03-03 | — | -0.8371 | — | $29.49M |
| 2026-10-29 | — | -0.8421 | — | $24.04M |
| 2026-08-12 | — | -0.8952 | — | $21.85M |
| 2026-05-12 | -0.83 | -0.6456 | $18.27M | $18.88M |
Related companies
